<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; NCD</title>
	<atom:link href="http://www.tapanray.in/tag/ncd/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Pharma To Facilitate Self-Managing Chronic Diseases For Better Outcomes?</title>
		<link>http://www.tapanray.in/pharma-to-facilitate-self-managing-chronic-diseases-for-better-outcomes/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=pharma-to-facilitate-self-managing-chronic-diseases-for-better-outcomes</link>
		<comments>http://www.tapanray.in/pharma-to-facilitate-self-managing-chronic-diseases-for-better-outcomes/#comments</comments>
		<pubDate>Mon, 07 Jan 2019 00:00:48 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[ailments]]></category>
		<category><![CDATA[Apple]]></category>
		<category><![CDATA[apps]]></category>
		<category><![CDATA[behavioral]]></category>
		<category><![CDATA[Change]]></category>
		<category><![CDATA[chronic. diseases]]></category>
		<category><![CDATA[companies]]></category>
		<category><![CDATA[facilitate]]></category>
		<category><![CDATA[Google]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[incidence]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[mHealth]]></category>
		<category><![CDATA[NCD]]></category>
		<category><![CDATA[NCDs]]></category>
		<category><![CDATA[need]]></category>
		<category><![CDATA[outcomes]]></category>
		<category><![CDATA[Patient]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[self-managing]]></category>
		<category><![CDATA[startups]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[tech]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[unmet]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9342</guid>
		<description><![CDATA[“India&#8217;s burden of non-communicable disease (NCD) is escalating, but still the country does not have sufficiently detailed data on NCDs for research and policy purposes.” This was captured in a recent study, titled “India&#8217;s escalating burden of non-communicable diseases,” published in The Lancet Global Health on &#8230; <a href="http://www.tapanray.in/pharma-to-facilitate-self-managing-chronic-diseases-for-better-outcomes/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/pharma-to-facilitate-self-managing-chronic-diseases-for-better-outcomes/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>An Interesting Link: Productivity At Work and Employee Fitness (In 2 Parts)</title>
		<link>http://www.tapanray.in/an-interesting-link-productivity-at-work-and-employee-fitness-in-2-parts/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=an-interesting-link-productivity-at-work-and-employee-fitness-in-2-parts</link>
		<comments>http://www.tapanray.in/an-interesting-link-productivity-at-work-and-employee-fitness-in-2-parts/#comments</comments>
		<pubDate>Mon, 16 Apr 2018 00:00:27 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[barrier]]></category>
		<category><![CDATA[benefits]]></category>
		<category><![CDATA[corporate]]></category>
		<category><![CDATA[exercises]]></category>
		<category><![CDATA[fitness]]></category>
		<category><![CDATA[IMPACT]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[mental]]></category>
		<category><![CDATA[NCD]]></category>
		<category><![CDATA[physical]]></category>
		<category><![CDATA[productivity]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[Think]]></category>
		<category><![CDATA[VUCA]]></category>
		<category><![CDATA[World]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=8929</guid>
		<description><![CDATA[Part 1: Physical Fitness Today’s work environment is much more challenging than ever before. The challenge is undoubtedly multi-factorial. Many of these are external – mostly related to increasing complex, and difficult to fathom uncertainties and surprises in the overall &#8230; <a href="http://www.tapanray.in/an-interesting-link-productivity-at-work-and-employee-fitness-in-2-parts/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/an-interesting-link-productivity-at-work-and-employee-fitness-in-2-parts/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>‘Digiceuticals’: A Force Multiplier to Contain Chronic Diseases</title>
		<link>http://www.tapanray.in/digiceuticals-a-force-multiplier-to-contain-chronic-diseases/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=digiceuticals-a-force-multiplier-to-contain-chronic-diseases</link>
		<comments>http://www.tapanray.in/digiceuticals-a-force-multiplier-to-contain-chronic-diseases/#comments</comments>
		<pubDate>Sun, 22 Oct 2017 23:30:15 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[app]]></category>
		<category><![CDATA[chronic]]></category>
		<category><![CDATA[consumer]]></category>
		<category><![CDATA[diabetes]]></category>
		<category><![CDATA[digiceuticals]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[disease]]></category>
		<category><![CDATA[disorders]]></category>
		<category><![CDATA[epidemic]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[NCD]]></category>
		<category><![CDATA[pull]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[smartphone]]></category>
		<category><![CDATA[Socioeconomic]]></category>
		<category><![CDATA[suppliers]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[Therapeutics]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=8373</guid>
		<description><![CDATA[There is a growing need for more effective prevention, treatment or management of many serious Noninfectious Chronic Diseases (NCDs), with greater safety and at a lesser cost. As a major step in this direction, ‘digiceuticals’ or ‘digital therapeutics’ are now &#8230; <a href="http://www.tapanray.in/digiceuticals-a-force-multiplier-to-contain-chronic-diseases/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/digiceuticals-a-force-multiplier-to-contain-chronic-diseases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>NCDs: Any Wolf Around, In Sheep’s Clothing? </title>
		<link>http://www.tapanray.in/ncds-any-wolf-around-in-sheeps-clothing/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=ncds-any-wolf-around-in-sheeps-clothing</link>
		<comments>http://www.tapanray.in/ncds-any-wolf-around-in-sheeps-clothing/#comments</comments>
		<pubDate>Mon, 08 Aug 2016 00:00:40 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[clothing]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[growth]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[IPM]]></category>
		<category><![CDATA[Modern]]></category>
		<category><![CDATA[NCD]]></category>
		<category><![CDATA[NLEM]]></category>
		<category><![CDATA[NPPA]]></category>
		<category><![CDATA[Parliament]]></category>
		<category><![CDATA[Patients]]></category>
		<category><![CDATA[Playbook]]></category>
		<category><![CDATA[price]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[sheep's]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[Wolf]]></category>
		<category><![CDATA[Wolf in sheep's clothing]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=7766</guid>
		<description><![CDATA[Noncommunicable Diseases (NCDs), such as, cancer, cardiovascular disease, diabetes and chronic respiratory disease, are now the leading cause of death in the world, accounting for 63 percent of annual deaths. Over 80 percent of NCDs occur in lower or middle &#8230; <a href="http://www.tapanray.in/ncds-any-wolf-around-in-sheeps-clothing/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/ncds-any-wolf-around-in-sheeps-clothing/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vaccines Development: Is it Just a Business Based on Fear?</title>
		<link>http://www.tapanray.in/vaccines-development-is-it-just-a-business-based-on-fear/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=vaccines-development-is-it-just-a-business-based-on-fear</link>
		<comments>http://www.tapanray.in/vaccines-development-is-it-just-a-business-based-on-fear/#comments</comments>
		<pubDate>Mon, 26 Aug 2013 00:00:26 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Based]]></category>
		<category><![CDATA[Bill]]></category>
		<category><![CDATA[Buchwald]]></category>
		<category><![CDATA[Business]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Costs]]></category>
		<category><![CDATA[diphtheria]]></category>
		<category><![CDATA[disease]]></category>
		<category><![CDATA[enough]]></category>
		<category><![CDATA[Expenses]]></category>
		<category><![CDATA[fear]]></category>
		<category><![CDATA[First]]></category>
		<category><![CDATA[Gates]]></category>
		<category><![CDATA[GAVI]]></category>
		<category><![CDATA[Gerhard]]></category>
		<category><![CDATA[global]]></category>
		<category><![CDATA[growth]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[JV]]></category>
		<category><![CDATA[local]]></category>
		<category><![CDATA[malaria]]></category>
		<category><![CDATA[market]]></category>
		<category><![CDATA[Merck]]></category>
		<category><![CDATA[MSD]]></category>
		<category><![CDATA[NCD]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[NIH]]></category>
		<category><![CDATA[Not]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[Partnership]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[pox]]></category>
		<category><![CDATA[prevention]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[research]]></category>
		<category><![CDATA[Sanofi]]></category>
		<category><![CDATA[small]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[TB]]></category>
		<category><![CDATA[threat]]></category>
		<category><![CDATA[Tuberculosis]]></category>
		<category><![CDATA[vaccination]]></category>
		<category><![CDATA[vaccines]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=3486</guid>
		<description><![CDATA[‘Vaccination – A Business based on fear’, is the title of a book written by Dr. Gerhard Buchwald M.D, a German medical doctor and a vaccination critic. This book talks about: “The damage and the deaths caused by vaccination are written &#8230; <a href="http://www.tapanray.in/vaccines-development-is-it-just-a-business-based-on-fear/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/vaccines-development-is-it-just-a-business-based-on-fear/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Ghost Keeps Haunting: NCD Dogs Cancer in &#8216;Compulsory License&#8217; Debate of India</title>
		<link>http://www.tapanray.in/the-ghost-keeps-haunting-ncd-dogs-cancer-in-compulsory-license-debate-of-india/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-ghost-keeps-haunting-ncd-dogs-cancer-in-compulsory-license-debate-of-india</link>
		<comments>http://www.tapanray.in/the-ghost-keeps-haunting-ncd-dogs-cancer-in-compulsory-license-debate-of-india/#comments</comments>
		<pubDate>Mon, 11 Mar 2013 00:00:12 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[agreement]]></category>
		<category><![CDATA[biologics]]></category>
		<category><![CDATA[biosimilar]]></category>
		<category><![CDATA[breast]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[Citizens']]></category>
		<category><![CDATA[CL]]></category>
		<category><![CDATA[collective]]></category>
		<category><![CDATA[companies]]></category>
		<category><![CDATA[Compulsory]]></category>
		<category><![CDATA[Dasatinib]]></category>
		<category><![CDATA[debate]]></category>
		<category><![CDATA[DIPP]]></category>
		<category><![CDATA[dogs]]></category>
		<category><![CDATA[DoP]]></category>
		<category><![CDATA[ghost]]></category>
		<category><![CDATA[haunting]]></category>
		<category><![CDATA[Herceptin]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[innovator]]></category>
		<category><![CDATA[IP]]></category>
		<category><![CDATA[IPR]]></category>
		<category><![CDATA[Ixabepilone]]></category>
		<category><![CDATA[keeps]]></category>
		<category><![CDATA[Legal]]></category>
		<category><![CDATA[leukemia]]></category>
		<category><![CDATA[License]]></category>
		<category><![CDATA[Minister]]></category>
		<category><![CDATA[NCD]]></category>
		<category><![CDATA[negotiation]]></category>
		<category><![CDATA[patented]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[PM]]></category>
		<category><![CDATA[price]]></category>
		<category><![CDATA[Prime]]></category>
		<category><![CDATA[products]]></category>
		<category><![CDATA[protein]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Roche]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[Trastuzumab]]></category>
		<category><![CDATA[treat]]></category>
		<category><![CDATA[TRIPS]]></category>
		<category><![CDATA[UN]]></category>
		<category><![CDATA[used]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=2037</guid>
		<description><![CDATA[In November 2012, as a part of the ‘Campaign for Affordable Trastuzumab’ for the treatment of breast cancer, a citizens’ collective, reportedly sent an ‘Open Letter’ signed by around 200 cancer survivors, women’s groups, human rights and health rights campaigns &#8230; <a href="http://www.tapanray.in/the-ghost-keeps-haunting-ncd-dogs-cancer-in-compulsory-license-debate-of-india/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/the-ghost-keeps-haunting-ncd-dogs-cancer-in-compulsory-license-debate-of-india/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Are Preventive Medicines always cost effective to be an area of focus in healthcare management?</title>
		<link>http://www.tapanray.in/are-preventive-medicines-always-cost-effective-to-be-an-area-of-focus-in-healthcare-management/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=are-preventive-medicines-always-cost-effective-to-be-an-area-of-focus-in-healthcare-management</link>
		<comments>http://www.tapanray.in/are-preventive-medicines-always-cost-effective-to-be-an-area-of-focus-in-healthcare-management/#comments</comments>
		<pubDate>Mon, 19 Mar 2012 00:00:21 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Always]]></category>
		<category><![CDATA[an]]></category>
		<category><![CDATA[area]]></category>
		<category><![CDATA[be]]></category>
		<category><![CDATA[Cost]]></category>
		<category><![CDATA[effective]]></category>
		<category><![CDATA[focus]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[management]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[NCD]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Preventive]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=119</guid>
		<description><![CDATA[American Board of Preventive Medicine defines ‘Preventive Medicine’ as follows: “Preventive Medicine is the specialty of medical practice that focuses on the health of individuals, communities, and defined populations. Its goal is to protect, promote, and maintain health and well-being &#8230; <a href="http://www.tapanray.in/are-preventive-medicines-always-cost-effective-to-be-an-area-of-focus-in-healthcare-management/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/are-preventive-medicines-always-cost-effective-to-be-an-area-of-focus-in-healthcare-management/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Non-Communicable Diseases (NCD) are hitting the poor even harder, economically: a time to ponder and a time to act</title>
		<link>http://www.tapanray.in/non-communicable-diseases-ncd-are-hitting-the-poor-even-harder-economically-a-time-to-ponder-and-a-time-to-act/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=non-communicable-diseases-ncd-are-hitting-the-poor-even-harder-economically-a-time-to-ponder-and-a-time-to-act</link>
		<comments>http://www.tapanray.in/non-communicable-diseases-ncd-are-hitting-the-poor-even-harder-economically-a-time-to-ponder-and-a-time-to-act/#comments</comments>
		<pubDate>Mon, 06 Dec 2010 00:30:39 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[Act]]></category>
		<category><![CDATA[Affordability]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[are]]></category>
		<category><![CDATA[Communicable]]></category>
		<category><![CDATA[Cost]]></category>
		<category><![CDATA[diseases]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[economically]]></category>
		<category><![CDATA[Even]]></category>
		<category><![CDATA[harder]]></category>
		<category><![CDATA[hitting]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[NCD]]></category>
		<category><![CDATA[Non]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[ponder]]></category>
		<category><![CDATA[poor]]></category>
		<category><![CDATA[price]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[time]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=339</guid>
		<description><![CDATA[November 11, 2010 edition of &#8216;The Lancet&#8217; published an article titled, “Raising the priority of preventing chronic diseases: a political process&#8221;. The article enumerated the following: “Chronic diseases, especially cardiovascular diseases, diabetes, cancer, and chronic obstructive respiratory diseases, are neglected &#8230; <a href="http://www.tapanray.in/non-communicable-diseases-ncd-are-hitting-the-poor-even-harder-economically-a-time-to-ponder-and-a-time-to-act/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/non-communicable-diseases-ncd-are-hitting-the-poor-even-harder-economically-a-time-to-ponder-and-a-time-to-act/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>National Non-Communicable Disease (NCD) prevention program of the government needs a new thrust to contain the burden of disease in India.</title>
		<link>http://www.tapanray.in/national-non-communicable-disease-ncd-prevention-program-of-the-government-needs-a-new-thrust-to-contain-the-burden-of-disease-in-india/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=national-non-communicable-disease-ncd-prevention-program-of-the-government-needs-a-new-thrust-to-contain-the-burden-of-disease-in-india</link>
		<comments>http://www.tapanray.in/national-non-communicable-disease-ncd-prevention-program-of-the-government-needs-a-new-thrust-to-contain-the-burden-of-disease-in-india/#comments</comments>
		<pubDate>Mon, 05 Apr 2010 00:30:06 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[burden]]></category>
		<category><![CDATA[Communicable]]></category>
		<category><![CDATA[contain]]></category>
		<category><![CDATA[disease]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[National]]></category>
		<category><![CDATA[NCD]]></category>
		<category><![CDATA[needs]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[Non]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[prevention]]></category>
		<category><![CDATA[program]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[thrust]]></category>
		<category><![CDATA[to]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=445</guid>
		<description><![CDATA[The disease pattern in India is showing a perceptible shift from the age old ‘Infectious Diseases’ to ‘Non-infectious Chronic Illnesses’. As reported by IMS, incidence of chronic ailments in India has increased from 23 percent in 2005 to 26 percent &#8230; <a href="http://www.tapanray.in/national-non-communicable-disease-ncd-prevention-program-of-the-government-needs-a-new-thrust-to-contain-the-burden-of-disease-in-india/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/national-non-communicable-disease-ncd-prevention-program-of-the-government-needs-a-new-thrust-to-contain-the-burden-of-disease-in-india/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
